NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Moebius Medical

Moebius Medical

Private
Tel AvivHealthcare & Life Scienceshttps://moebiusmedical.com/

Last Round

Corporate Funding

Dec 12, 2016

Total Funding Raised

$100,000

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Moebius Medical is a drug discovery company that develops novel treatments for osteoarthritis (OA).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Hardware Sales

AI Layer

Non-AI

Keywords

osteoarthritis treatmentliposomal technologynon-opioid pain reliefknee osteoarthritisintra-articular injectionbiolubricationclinical-stage biotechnologyhyaluronic acid alternativecorticosteroid alternativeknee injectiondrug licensingPhase 3 clinical trialjoint lubricationFDA Fast Trackcartilage repairviscosupplementation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Moebius Medical Comparables

Compare Moebius Medical with similar companies based on industry and business-model similarity.

Moebius Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Eupraxia Pharmaceuticals Inc.
79%
Lubris BioPharma
78%
Levicept
77%

Moebius Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingDec 12, 2016
AcceleratorSep 1, 2008
SeedAug 1, 2008

Key People

Founding team and executive leadership

Moshe Weinstein

CEO & Board Member

Executive Team

Yonatan Cohavi

Chief Financial Officer

Executive Team

Moebius Medical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 3118% MoM, reaching 5.9K.

  • Apr 16, 2026

    Monthly visitors grew 286% MoM, from 383 to 1.5K.

Moebius Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Moebius Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Moebius Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersTel Aviv
Employee Range4
Year Founded2008
Last FundingDec 12, 2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.